FDA [Food and Drug Administration] commissioner Scott Gottlieb yesterday called on brand name drug companies to end the shenanigans that restrict generic drug competition, specifically pointing to the tactic of slow-playing shared Risk Evaluation and Mitigation Strategies (REMS) terms intended to prevent generic manufacturers from purchasing drug products needed to run bioequivalence or bioavailability studies that FDA approval requires.

If the governor of Kentucky is now making colonels by the wholesale, he is doing it “for a reason.” It is a mere unfortunate incident, for him, that he can not make colonelesses and majoresses. The grip of the appointive power on the women is even stronger than on the men.

[Ignatz, under the rain:] It's a good thing I had this tarp handy. … / [Officer Pupp:] Gimme that canvas, it's much more important that I keep dry.

I taught myself.